SPH-260-4

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameSPH-260-4
Drug Alias Namedelmopinol (Sinclair IS Pharma)SPH-260-4
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSinclair Pharma PLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSinclair Pharma PLC
Active IndicationsN/A
Inactive IndicationsBacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A